Naresh K. Nayyar
Consigliere Generale presso TURG POIN
Profilo
Naresh K.
Nayyar is currently the Vice President-Regulatory Affairs at Turning Point Therapeutics, Inc. Prior to this, he worked as the Associate Vice President-Regulatory Affairs at aTyr Pharma, Inc. from 2016 to 2018.
Nayyar holds an MBA from the University of Phoenix and a doctorate from the University of Delhi.
Posizioni attive di Naresh K. Nayyar
| Società | Posizione | Inizio |
|---|---|---|
| TURG POIN | Consigliere Generale | 01/06/2018 |
Precedenti posizioni note di Naresh K. Nayyar
| Società | Posizione | Fine |
|---|---|---|
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01/05/2018 |
Formazione di Naresh K. Nayyar
| University of Delhi | Doctorate Degree |
| University of Phoenix | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Naresh K. Nayyar
